Shenzhen Weiguang Biological Products Co., Ltd.
002880.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.47B
Close$
Share Statistics
| Market cap | $4.47 Billion |
|---|---|
| Enterprise Value | $5.26 Billion |
| Dividend Yield | $0.20 (1.02%) |
| Earnings per Share | $1.09 |
| Beta | 0.27 |
| Outstanding Shares | 226,800,000 |
Return
| Return on Equity | 7.59% |
|---|---|
| Return on Assets | 5.08% |
| Return on Invested Capital | 7.66% |
Valuation & Multiples
| P/E Ratio | 24.35 |
|---|---|
| PEG | -30.81 |
| Price to Sales | 3.94 |
| Price to Book Ratio | 1.97 |
| Enterprise Value to Revenue | 4.39 |
| Enterprise Value to EBIT | 22.87 |
| Enterprise Value to Net Income | 28 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shenzhen Weiguang Biological Products Co., Ltd.
901 employees
CEO: Caiping Guo Shenzhen Weiguang Biological Products Co., Ltd. is a Chinese enterprise primarily dedicated to the entire lifecycle of blood products, encompassing their research, development, manufacturing, and distribution within the domestic market. ...